Date
- 2026 (21)
- 2025 (32)
- 2024 (18)
- 2023 (44)
- 2022 (38)
- 2021 (36)
- 2020 (58)
- 2019 (31)
- 2018 (47)
- 2017 (11)
- 2016 (44)
- 2015 (36)
- 2014 (10)
- 2013 (12)
- 2012 (3)
- 2011 (6)
- 2010 (27)
- 2009 (4)
- 2008 (15)
- 2007 (1)
- 2006 (4)
- 2005 (10)
- 2004 (4)
- 2003 (5)
- 2002 (7)
- 2001 (5)
- 2000 (8)
- 1999 (2)
- 1998 (2)
- 1997 (4)
- 1996 (3)
- 1995 (4)
- 1993 (10)
- 1992 (3)
- 1991 (12)
Sponsor content
577 result(s) found, displaying 141 to 150
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ENERZAIR BREEZHALER 114/46/68 indacaterol/glycopyrronium/mometasone furoate 114/46/68 microgram powder for inhalation in capsule with inhaler.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ENERZAIR BREEZHALER 114/46/136 indacaterol/glycopyrronium/mometasone furoate 114/46/136 microgram powder for inhalation in capsule with inhaler.
-
Prescription medicine registrationActive ingredients: asciminib hydrochloride.
-
Cancellation by sponsorRequested by Novartis Pharmaceuticals Australia Pty Ltd
-
Cancellation by sponsorRequested by Novartis Pharmaceuticals Australia Pty Ltd
-
Cancellation by sponsorRequested by Novartis Pharmaceuticals Australia Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LUXTURNA voretigene neparvovec 5 x 10(12) (vg) per mL concentrate solution for injection vial with diluent ampoule.
-
Cancellation by sponsorRequested by Novartis Pharmaceuticals Australia Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ATECTURA BREEZHALER 125/260 indacaterol (as acetate)/mometasone furoate 125/260 microgram powder for inhalation in hard capsule with inhaler.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ATECTURA BREEZHALER 125/62.5 indacaterol (as acetate)/mometasone furoate 125/62.5 microgram powder for inhalation in hard capsule with inhaler.